BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30105657)

  • 1. Effectiveness and Tolerability of Micafungin in Chinese Patients with Invasive Fungal Infections: A Retrospective, Multicenter Study.
    Zheng X; Huang X; Luo J; Li J; Li W; Liu Q; Niu T; Wang X; Zhou J; Zhang X; Hu J; Liu K
    Adv Ther; 2018 Sep; 35(9):1400-1410. PubMed ID: 30105657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
    Moen MD; Lyseng-Williamson KA; Scott LJ
    Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients.
    Park S; Kim K; Jang JH; Kim SJ; Kim WS; Chung DR; Kang CI; Peck KR; Jung CW
    J Infect; 2016 Nov; 73(5):496-505. PubMed ID: 27394404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Invasive Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: The Turin Experience.
    Busca A; Cinatti N; Gill J; Passera R; Dellacasa CM; Giaccone L; Dogliotti I; Manetta S; Corcione S; De Rosa FG
    Front Cell Infect Microbiol; 2021; 11():805514. PubMed ID: 35071052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of micafungin as antifungal prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) in Spain (GETH-MIC).
    López-Sánchez C; Valcárcel D; Gómez V; López-Jiménez J; Serrano D; Rubio V; Solano C; Vázquez L; Ruiz I;
    Rev Esp Quimioter; 2020 Apr; 33(2):110-115. PubMed ID: 32056418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of invasive fungal infections in intensive care units with micafungin: The MYRIADE study.
    Timsit JF; Leverger G; Milpied N; Gachot B
    Mycoses; 2020 May; 63(5):443-451. PubMed ID: 32048344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micafungin for Candida infections in Slovenia and Romania: A multicenter, observational, prospective study.
    Zver S; Avcin S; Bedreag O; Bizilj S; Ecrulj V; Jazbec J; Puconja N; Stanic R; Jereb M
    J Infect Dev Ctries; 2021 Jun; 15(6):877-888. PubMed ID: 34242200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis.
    Kubiak DW; Bryar JM; McDonnell AM; Delgado-Flores JO; Mui E; Baden LR; Marty FM
    Clin Ther; 2010 Apr; 32(4):637-48. PubMed ID: 20435233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of micafungin as an empirical therapy for invasive fungal infections in patients with hematologic disorders: a multicenter, prospective study.
    Yamaguchi M; Kurokawa T; Ishiyama K; Aoki G; Ueda M; Matano S; Takami A; Yamazaki H; Sawazaki A; Yamauchi H; Yoshida T; Nakao S
    Ann Hematol; 2011 Oct; 90(10):1209-17. PubMed ID: 21695388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Micafungin for the Prevention and Treatment of Invasive Fungal Infections in Everyday Pediatric Care in France: Results of the MYRIADE Study.
    Leverger G; Timsit JF; Milpied N; Gachot B
    Pediatr Infect Dis J; 2019 Jul; 38(7):716-721. PubMed ID: 31192976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haplo-identical hematopoietic SCT.
    El-Cheikh J; Venton G; Crocchiolo R; Fürst S; Faucher C; Granata A; Oudin C; Coso D; Bouabdallah R; Vey N; Duran S; Fougereau E; Berger P; Chabannon C; Blaise D
    Bone Marrow Transplant; 2013 Nov; 48(11):1472-7. PubMed ID: 23749104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micafungin prophylaxis in routine medical practice in adult and pediatric patients with hematological malignancy: a prospective, observational study in France.
    El Cheikh J; Ceballos P; Dalle JH; Ducastelle-Leprêtre S; Dulon E; Herbrecht R
    Diagn Microbiol Infect Dis; 2019 Jul; 94(3):268-273. PubMed ID: 30842034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness, Tolerability, and Safety of Different Amphotericin B Formulations in Invasive Fungal Infections: A Multicenter, Retrospective, Observational Study.
    Cavassin FB; Magri MMC; Vidal JE; de Moraes Costa Carlesse FA; Falci DR; Baú-Carneiro JL; Breda GL; de Araújo Motta F; de Miranda Godoy CS; de Bastos Ascenço Soares R; De Oliveira CS; Mendes AVA; Morales HP; Montes PS; Taborda M; Rego CM; Félix MA; Katopodis PP; da Silva do Ó JR; Abrão MPL; Pereira TTT; Queiroz-Telles F
    Clin Ther; 2024 Apr; 46(4):322-337. PubMed ID: 38403508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Multicenter, Randomized, Open-Label Study to Compare Micafungin with Fluconazole in the Prophylaxis of Invasive Fungal Infections in Living-Donor Liver Transplant Recipients.
    Kang WH; Song GW; Lee SG; Suh KS; Lee KW; Yi NJ; Joh JW; Kwon CHD; Kim JM; Choi DL; Kim JD; Kim MS
    J Gastrointest Surg; 2020 Apr; 24(4):832-840. PubMed ID: 31066013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and Safety of Micafungin in Managing Invasive Fungal Infections among Patients in Greece with Hematologic Disorders: The ASPIRE Study.
    Kotsopoulou M; Papadaki C; Anargyrou K; Spyridonidis A; Baltadakis I; Papadaki HA; Angelopoulou M; Pappa V; Liakou K; Tzanetakou M; Moustaka M; Vassilopoulos G
    Infect Dis Ther; 2019 Jun; 8(2):255-268. PubMed ID: 30767170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micafungin versus posaconazole prophylaxis in acute leukemia or myelodysplastic syndrome: A randomized study.
    Epstein DJ; Seo SK; Huang YT; Park JH; Klimek VM; Berman E; Tallman MS; Frattini MG; Papanicolaou GA
    J Infect; 2018 Sep; 77(3):227-234. PubMed ID: 29746955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of micafungin, an echinocandin antifungal agent, on invasive fungal infections in patients with hematological disorders.
    Tamura K; Urabe A; Yoshida M; Kanamaru A; Kodera Y; Okamoto S; Maesaki S; Masaoka T
    Leuk Lymphoma; 2009 Jan; 50(1):92-100. PubMed ID: 19172498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breakthrough Invasive Fungal Infections in Patients with Acute Myeloid Leukemia.
    Wasylyshyn A; Linder KA; Castillo CG; Zhou S; Kauffman CA; Miceli MH
    Mycopathologia; 2020 Apr; 185(2):299-306. PubMed ID: 31939052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy.
    Park H; Youk J; Shin DY; Hong J; Kim I; Kim NJ; Lee JO; Bang SM; Yoon SS; Park WB; Koh Y
    BMC Cancer; 2019 Apr; 19(1):358. PubMed ID: 30991992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical Trial.
    Timsit JF; Azoulay E; Schwebel C; Charles PE; Cornet M; Souweine B; Klouche K; Jaber S; Trouillet JL; Bruneel F; Argaud L; Cousson J; Meziani F; Gruson D; Paris A; Darmon M; Garrouste-Orgeas M; Navellou JC; Foucrier A; Allaouchiche B; Das V; Gangneux JP; Ruckly S; Maubon D; Jullien V; Wolff M;
    JAMA; 2016 Oct; 316(15):1555-1564. PubMed ID: 27706483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.